Segue triples down after lithium exploration work


Published 10-JUN-2016 14:51 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Segue Resources (ASX:SEG) is so convinced by it lithium chances at its Gascoyne project that it has applied to almost treble the amount of land it holds at the play.

Releasing a note to its investors yesterday, SEG said that initial fieldwork at the project had been done – with 65 rock chip samples taken confirming that the northern part of the project is fertile and holds the potential to for lithium deposits.

SEG said key metrics including magnesium/lithium ratios meant the northern part of its existing licenses were “unequivocally fertile”.

It has centred in on one key geological feature, the Thirty Three Supersuite – which SEG said had key comparisons with North Pilbara deposits including the Wodinga and the Tanco pegmatite in Canada.

Based on the rock chip results, SEG has applied for of additional licenses in the area – potentially bringing its holding in the area up to

A map of SEG's tenements

A map of SEG’s tenements

It said the new area would cover the majority of the Thirty Three Supersuite and the prospective area identified.

The new area will be the focus of SEG’s next phase of exploration at the project, which is due to start in the third quarter.

SEG managing director Steven Michael said the exploration work was a boon to the company.

“Segue has proved that the Thirty Three Supersuite is highly fertile for lithium-bearing minerals,” he said.

“The initial exploration results have prompted Segue to increase its exploration licence holding in the area, with the majority of the prospective geology under Segue’s control.”

More on SEG and Gascoyne Lithium

Back in March SEG entered an agreement with Next Advancements Pty Ltd to acquire a 100% stake in three exploration licenses in the Gascoyne region of WA.

It then entered a joint venture with Zeus Resources Ltd (ASX:ZEU) to explore at exploration license E09/1618 – which is next door to the Next Advancements licenses.

SEG is getting into lithium as an accent to its nickel play in the Fraser Range, also in WA.

Dubbed the ‘Plumridge Project’, it’s a collection of eight exploration licenses covering 2250 in the Fraser Range, and is just 150km north-west of the Nova and Bollinger nickel discoveries which famously put Sirrius Resources shares on a tear.

Prior to a joint venture with MMG Limited (ASX:MMG) forming in September last year, Segue had completed several surveys over the project area.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free